Submit Manuscript Now
Current issue Archive Authors Profile
Research Articles Issue 2 · 2014 · pp. 254–260 · Issue page

THROMBOPHILIAS– PREGNANCY RELATED RISK CATEGORIES

IU
Iulia SAVU1
1 MD, PhD Student, Dept. of Obstetrics-Gynecology, Life Memorial Hospital Bucharest
Corresponding author: [email protected]
Accepted 26 March 2026
Available Online 15 November 2014
Abstract
THROMBOPHILIA REPERESENT A GROUP OF PROTHROMBOTIC CONDITIONS, EITHER AQUIRED OR INHERITED, WHICH PREDISPOSE TO THROMBOEMBOLISM. IT IS CHARACTERISED BY A HYPERCOAGULABLE STATE, A TENDENCY OFTEN REPETEAD OVER AN EXTENDED PERIOD OF TIME, WHICH CAN LEAD TO VENOUS THROMBOEMBOLISM AND/OR OBSTETRICAL SEVERE ADVERSE OUTCOMES. RECENTLY HAS BEEN SHOWN THAT THROMBOPHILIA IS ASSOCIATED WITH SEVERE PREECLAMPSIA, STILLBIRTH, ABRUPTIO PLACENTAE, RECURRENT FETAL LOSS AND INTRAUTERINE GROUTH RETARDATION. THIS REVIEW AIMS TO PROVIDE AN OVERVIEW OF THE DIFFERENT THROMBOPHILIAS, ACCORDING TO THEIR ETHIOGENY, CLINICAL EFFECTS AND PREGANCY RELATED RISK CATEGORY. THE LATEST THERAPEUTIC STRATEGIES ARE ALSO TAKEN INTO ACCOUNT.
Keywords
THROMBOPHILIA PREGNANCY INHERITED AQUIRED
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Alfirevic Z, Roberts D, Martlew V . How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101:6– 14.
[2]
American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy.Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2013 Sep. 12 p. (ACOG practice bulletin; no. 138)
[3]
Bank I, Libourel EJ, Middeldorp S, et al. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy -related complications in a family study. Arch Intern Med 2004;164:1932–7.
[4]
Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy: American College of Chest Physicians Evidence-based Practice Guidelines (8th edition) American College of Chest Physicians. Chest 2008; 133:844S-886S.
[5]
Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005;293:2352–61.
[6]
Coppens M, Van de Poel MH, Hamulyak K , et al. Incidence of venous and arterial thromboembolism in asymptomatic carriers of the prothrombin 20210A mutation prospective cohort study. J Thromb Haemost 2005;3(Suppl 1):P0459.
[7]
den Heijer M, Willems H, Blom HJ , et al. Homocysteine lowering by B vitamins and thesecondary prevention of deep -vein thrombosis and pulmonary embolism. A randomised, placebo -controlled, double blind trial. J Thromb Haemost 2005;3:H03.
[8]
DiNisio M, Peters LW, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antipho spholipid syndrome. The Cochrane Database of Systematic Reviews 2005;CD004734.
[9]
Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004;91:700–11.
[10]
Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox -Gill J et al. Antithrombotic therapy and pregnancy:consensus report and recommendations for preventing and treatment of thromboembolism and adverse pregnancy outcome. Pregnancy and Thrombosis Working Group. Am J Obstet Gynecol 2007;197:457.1-457.21.
[11]
Empson M, Lassere M, Craig JC , et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systematic Reviews. 2005;CD002859.
[12]
Kovalevsky G, Gracia CR, B erlin JA , et al. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004;164:558–63.
[13]
Krabbendam I, Franx A, Bots ML , et al. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 2005;118:143–53.
[14]
Lin J, August P . Genetic thrombophilias and preeclampsia: a meta -analysis. Obstet Gynecol 2005;105:182–92.
[15]
Middeldorp S, Meinardi JR, Koopman MM , et al. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 2001;135:322–7.
[16]
Middeldorp S, Van de Poel MH, Bank I, et al. Unselected women with elevated levels of factor VIII:C or homocysteine a re not at increased risk for obstetric complications. Thromb Haemost 2004;92:787–90.
[17]
Morrison ER, Miedzybrodzka ZH, Campbell DM, et al. Prothrombotic genotypes are not associated with pre -eclampsia and gestational hypertension: results from a large populat ionbased study and systematic review. Thromb Haemost 2002;87:779–85.
[18]
Pabinger I, Grafenhofer H, Kaider A , et al. Risk of pregnancy -associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost 2005; 3:949–54.
[19]
Rey E, Kahn SR, David M , et al. Thrombophilic disorders and fetal loss: a meta -analysis. Lancet 2003;361:901–8.
[20]
Van de Poel MH, Coppens M, Middeldorp S , et al. Absolute risk of venous and arterial thromboembolism associated with mild hyperhomocysteinemia. Re sults from a retrospective family cohort study. J Thromb Haemost 2005;3(Suppl 1):P0481.